A. Hirasawa et al., EFFECTS OF A NEW FORSKOLIN DERIVATIVE, NKH477, ON CANINE VENTRICULAR ARRHYTHMIA MODELS, Journal of cardiovascular pharmacology, 22(6), 1993, pp. 847-851
Using two-stage coronary ligation-, digitalis- and epinephrine-induced
canine ventricular arrhythmia models, we examined whether a new posit
ive inotropic agent, NKH477, 6-(3-dimethylaminopropionyl)forskolin hyd
rochloride, a water-soluble derivative of forskolin, had deleterious e
ffects on arrhythmias. NKH477 increased heart rate (HR) and decreased
blood pressure (BP) in dogs with all the arrhythmia models. Unexpected
ly, NKH477 suppressed digitalis- and epinephrine-induced arrhythmias,
but did not suppress two-stage coronary ligation arrhythmia or aggrava
te it. These results indicate that NKH477, unlike other new positive i
notropic agents such as amrinone, milrinone, sulmazole and vesnarinone
, did not worsen these arrhythmias; thus, NKH477 may be a useful posit
ive inotropic agent with little arrhythmogenic effect.